The upregulation of HO-1 after chemotherapy in cancer cells can mitigate ROS-mediated oxidative damage and counteract chemotherapeutic agent-induced cytotoxicity, which contributes to acquired chemoresistance. The gene discussed is HMOX1; the disease is cancer.